Optera Diagnostics

What: Healthcare startup revolutionizing cancer tissue analysis.
Innovation: Improve wait time for biopsy results and patient outcomes.
Who: Founder is Linden Wyatt, who has three degrees – a B.S. physics/math, a PhD physics, and an MBA.
Market: Cancer treatment
Idea: Working to commercialize an instrument that gives clinicians critical information in real time during resection and biopsy surgical procedures.
Notes: Licensed IP pHLIP, Inc. Optera is also the winner of the Cox Business Startup Competition Audience Choice Award, and was a runner-up in the Rhode Island Business Plan Elevator Pitch Competition.